EP 3609329 A1 20200219 - COMPOSITIONS, PACKAGED PHARMACEUTICALS, AND METHODS OF USING POSACONAZOLE FOR THE SENSITIZATION OF RESISTANT TUMORS
Title (en)
COMPOSITIONS, PACKAGED PHARMACEUTICALS, AND METHODS OF USING POSACONAZOLE FOR THE SENSITIZATION OF RESISTANT TUMORS
Title (de)
ZUSAMMENSETZUNGEN, VERPACKTE ARZNEIMITTEL UND VERFAHREN ZUR VERWENDUNG VON POSACONAZOL ZUR SENSIBILISIERUNG RESISTENTER TUMOREN
Title (fr)
COMPOSITIONS, PRODUITS PHARMACEUTIQUES CONDITIONNÉS, ET MÉTHODES D'UTILISATION DE POSACONAZOLE POUR LA SENSIBILISATION DE TUMEURS RÉSISTANTES
Publication
Application
Priority
- US 201762484852 P 20170412
- US 2018027371 W 20180412
Abstract (en)
[origin: WO2018191541A1] Compositions, packaged pharmaceuticals, and methods of treatment by the sensitization of resistant tumors are provided. The compositions comprise posaconazole and a chemotherapeutic agent. Tumor cells in mammalian subjects treated with posaconazole are sensitized to the effects of the chemotherapeutic agent, thus increasing the therapeutic index of the agent and reducing toxicity to the subject.
IPC 8 full level
A01N 43/48 (2006.01); A61K 31/496 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP KR)
A61K 31/337 (2013.01 - EP KR); A61K 31/475 (2013.01 - EP KR); A61K 31/496 (2013.01 - EP KR); A61K 45/06 (2013.01 - EP KR); A61P 35/00 (2017.12 - EP KR); A61K 2300/00 (2013.01 - KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2018191541 A1 20181018; AU 2018253189 A1 20191205; CA 3063115 A1 20181018; CN 111093373 A 20200501; EP 3609329 A1 20200219; EP 3609329 A4 20210317; KR 20200059188 A 20200528
DOCDB simple family (application)
US 2018027371 W 20180412; AU 2018253189 A 20180412; CA 3063115 A 20180412; CN 201880038812 A 20180412; EP 18783809 A 20180412; KR 20197033474 A 20180412